| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |